The Covid pill will be rolled out before Christmas – .

The Covid pill will be rolled out before Christmas – .

In addition to Lagevrio’s 480,000 courses, the UK has ordered 250,000 courses of Ritonavir, a medicine produced by Pfizer which is generally used to treat HIV / AIDS. However, ritonavir has not yet received approval from the MHRA.

Lagevrio, produced by Ridgeback Biotherapeutics and Merck Sharp & Dohme, works by preventing the Covid virus from multiplying, keeping levels low in the body, and reducing the severity of illness. The MHRA said the drug should be taken as soon as possible after a positive Covid test and within the first five days of symptoms.

Patients who will be eligible under the MHRA decision will have at least one risk factor for developing severe Covid, including obesity, diabetes, heart disease, or being over 60 years old.

A snapshot of the study published by the Antivirals Taskforce this summer said it would examine the impact of treatments on clinically vulnerable patients who test positive for Covid, as well as some non-vulnerable household contacts of those who test positive . It is not clear whether non-vulnerable people will always be included in the pilot.

The government appears to have lowered the original ambition of the UK Antivirals Task Force, set up by Mr Javid’s predecessor Matt Hancock, in April, to potentially offer treatment to all Covid patients instead to provide drugs to those deemed clinically vulnerable, including people with existing medical preconditions who cannot be vaccinated.

As the omicron variant continues to spread in the UK, government advisers have suggested that an extension of the current requirement to wear masks in shops and on public transport until the New Year may now be inevitable. .

“I suspect it may be [extended] Said a member of the Sage Scientific Advisory Board. “We know these restrictions work and can be used in a mass setting. “

Several Cabinet ministers said they considered the current restrictions “proportionate” while ministers waited for the first data on the link between omicron, hospitalizations and deaths.

A senior minister warned that while they “may cope” with extending the mask-wearing requirement beyond the initial three-week examination mark later this month, the maintenance of the new self-isolation requirement for vaccinated contacts of people with omicron would experience “some hindsight” in the absence of data to support the decision.


Please enter your comment!
Please enter your name here